Long-term functional restoration by neural progenitor cell transplantation in rat model of cognitive dysfunction: co-transplantation with olfactory ensheathing cells for neurotrophic factor support

International Journal of Developmental Neuroscience

Volumn 27, Issue 1, 2009, Pages 103-110

  Srivastava, N ^a   Seth, K ^a   Khanna, V K ^a   Ansari, R W ^a   Agrawal, A K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Choline acetyltransferase; Co transplantation; Cognitive dysfunction; Kainic acid; Neural progenitor cells; Olfactory ensheathing cells; Y maze

Indexed keywords

CHOLINERGIC RECEPTOR; KAINIC ACID; NEUROTROPHIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CELL DIFFERENTIATION; CELL TRANSPLANTATION; COGNITIVE DEFECT; CONTROLLED STUDY; FETUS; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; LEARNING; MAZE TEST; MEMORY; NEUROCHEMISTRY; NONHUMAN; OLFACTORY CORTEX; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; KAINIC ACID; MALE; NERVE GROWTH FACTORS; NERVE REGENERATION; NEUROGLIA; NEUROTOXINS; OLFACTORY BULB; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

EID: 58249088720     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.08.002     Document Type: Article

References (64)

1. Agrawal A.K., Shukla S., Chaturvedi R.K., Seth K., Srivastava N., Ahmad A., and Seth P.K. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a co-transplantation approach with fetal ventral mesencephalic cells. Neurobiol. Dis. 16 3 (2004) 516-526
2. Agrawal A.K., Squibb R.E., and Bondy S.C. The effects of acrylamide treatment upon the dopamine receptor. Toxicol. Appl. Pharmacol. 58 1 (1981) 89-99
3. Archer H.A., McFarlane F., Frost C., Cutler D., Fox N.C., and Rossor M.N. Symptoms of memory loss as predictors of cognitive impairment? The use and reliability of memory ratings in a clinic population. Alzheimer Dis. Assoc. Disord. 21 2 (2007) 101-106
4. Au E., Richter M.W., Vincent A.J., Tetzlaff W., Aebersold R., Sage E.H., and Roskams A.J. SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J. Neurosci. 27 27 (2007) 7208-7221
5. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 163 2 (2000) 495-529
6. Bassant M.H., Poindessous-Jazat F., and Schmidt B.H. Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats. Eur. J. Pharmacol. 387 2 (2000) 151-162
7. Bellucci A., Luccarini I., Scali C., Prosperi C., Giovannini M.G., Pepeu G., and Casamenti F. Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol. Dis. 23 2 (2006) 260-272
8. Benzing C., Segschneider M., Leinhaas A., Itskovitz-Eldor J., and Brustle O. Neural conversion of human embryonic stem cell colonies in the presence of fibroblast growth factor-2. Neuroreport 17 16 (2006) 1675-1681
9. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 9533 (2006) 387-403
10. Boyd J.G., Doucette R., and Kawaja M.D. Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord. FASEB J. 19 7 (2005) 694-703
11. Boyd J.G., Skihar V., Kawaja M., and Doucette R. Olfactory ensheathing cells: historical perspective and therapeutic potential. Anat. Rec. B, New Anat. 271 1 (2003) 49-60
12. Carvey P.M., Ling Z.D., Sortwell C.E., Pitzer M.R., McGuire S.O., Storch A., and Collier T.J. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease. Exp. Neurol. 171 1 (2001) 98-108
13. Chaturvedi R.K., Agrawal A.K., Seth K., Shukla S., Chauhan S., Shukla Y., Sinha C., and Seth P.K. Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Int. J. Dev. Neurosci. 21 7 (2003) 391-400
14. Chaturvedi R.K., Shukla S., Seth K., and Agrawal A.K. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Neurosci. Lett. 398 1/2 (2006) 44-49
15. Chaturvedi R.K., Shukla S., Seth K., and Agrawal A.K. Zuckerkandl's organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats. Exp. Neurol. 210 2 (2008) 608-623
16. Chen Q., Long Y., Yuan X., Zou L., Sun J., Chen S., Perez-Polo J.R., and Yang K. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J. Neurosci. Res. 80 5 (2005) 611-619
17. Fairless R., and Barnett S.C. Olfactory ensheathing cells: their role in central nervous system repair. Int. J. Biochem. Cell Biol. 37 4 (2005) 693-699
18. Franssen E.H., de Bree F.M., and Verhaagen J. Olfactory ensheathing glia: their contribution to primary olfactory nervous system regeneration and their regenerative potential following transplantation into the injured spinal cord. Brain Res. Rev. 56 1 (2007) 236-258
19. Gage F.H. Mammalian neural stem cells. Science 287 5457 (2000) 1433-1438
20. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., and Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9 5 (2003) 589-595
21. Hattiangady B., Rao M.S., Zaman V., and Shetty A.K. Incorporation of embryonic CA3 cell grafts into the adult hippocampus at 4-months after injury: effects of combined neurotrophic supplementation and caspase inhibition. Neuroscience 139 4 (2006) 1369-1383
22. Hong S., Kang U.J., Isacson O., and Kim K.S. Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons. J. Neurochem. 104 2 (2008) 316-324
23. Kamei N., Tanaka N., Oishi Y., Hamasaki T., Nakanishi K., Sakai N., and Ochi M. BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic co-cultures. Spine 32 12 (2007) 1272-1278
24. Kornblum H.I. Introduction to neural stem cells. Stroke 38 suppl. 2 (2007) 810-816
25. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10 Suppl. (2004) S42-S50
26. Llado J., Haenggeli C., Maragakis N.J., Snyder E.Y., and Rothstein J.D. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol. Cell. Neurosci. 27 3 (2004) 322-331
27. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 1 (1951) 265-275
28. Marshall C.T., Lu C., Winstead W., Zhang X., Xiao M., Harding G., Klueber K.M., and Roisen F.J. The therapeutic potential of human olfactory-derived stem cells. Histol. Histopathol. 21 6 (2006) 633-643
29. Mesulam M. The cholinergic lesion of Alzheimer's disease: pivotal factor or side show?. Learn. Mem. 11 1 (2004) 43-49
30. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 5651 (2003) 1760-1765
31. Pastrana E., Moreno-Flores M.T., Gurzov E.N., Avila J., Wandosell F., and Diaz-Nido J. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J. Neurosci. 26 20 (2006) 5347-5359
32. Picard-Riera N., Nait-Oumesmar B., and Baron-Van Evercooren A. Endogenous adult neural stem cells: limits and potential to repair the injured central nervous system. J. Neurosci. Res. 76 2 (2004) 223-231
33. Pluchino S., Zanotti L., Deleidi M., and Martino G. Neural stem cells and their use as therapeutic tool in neurological disorders. Brain Res. Brain Res. Rev. 48 2 (2005) 211-219
34. Pratico D., and Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am. J. Med. 109 7 (2000) 577-585
35. Raisman G. Repair of spinal cord injury by transplantation of olfactory ensheathing cells. C R Biol 330 6/7 (2007) 557-560
36. Ramirez J.J., Finklestein S.P., Keller J., Abrams W., George M.N., and Parakh T. Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport 10 6 (1999) 1201-1204
37. Ramon-Cueto A., Cordero M.I., Santos-Benito F.F., and Avila J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25 2 (2000) 425-435
38. Rothstein J.D., and Snyder E.Y. Reality and immortality-neural stem cells for therapies. Nat. Biotechnol. 22 3 (2004) 283-285
39. Row B.W., Kheirandish L., Cheng Y., Rowell P.P., and Gozal D. Impaired spatial working memory and altered choline acetyltransferase (CHAT) immunoreactivity and nicotinic receptor binding in rats exposed to intermittent hypoxia during sleep. Behav. Brain Res. 177 2 (2007) 308-314
40. Ruitenberg M.J., Vukovic J., Sarich J., Busfield S.J., and Plant G.W. Olfactory ensheathing cells: characteristics, genetic engineering, and therapeutic potential. J. Neurotrauma 23 3/4 (2006) 468-478
41. Salinas M., Diaz R., Abraham N.G., Ruiz de Galarreta C.M., and Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278 16 (2003) 13898-13904
42. Sasaki M., Li B., Lankford K.L., Radtke C., and Kocsis J.D. Remyelination of the injured spinal cord. Prog. Brain Res. 161 (2007) 419-433
43. Schumm M.A., Castellanos D.A., Frydel B.R., and Sagen J. Enhanced viability and neuronal differentiation of neural progenitors by chromaffin cell co-culture. Brain Res. Dev. Brain Res. 137 2 (2002) 115-125
44. Schumm M.A., Castellanos D.A., Frydel B.R., and Sagen J. Improved neural progenitor cell survival when cografted with chromaffin cells in the rat striatum. Exp. Neurol. 185 1 (2004) 133-142
45. Shimoke K., and Chiba H. Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson's disease. J. Neurosci. Res. 63 5 (2001) 402-409
46. Shindo T., Matsumoto Y., Wang Q., Kawai N., Tamiya T., and Nagao S. Differences in the neuronal stem cells survival, neuronal differentiation and neurological improvement after transplantation of neural stem cells between mild and severe experimental traumatic brain injury. J. Med. Invest. 53 1/2 (2006) 42-51
47. Shukla S., Agrawal A.K., Chaturvedi R.K., Seth K., Srivastava N., Sinha C., Shukla Y., Khanna V.K., and Seth P.K. Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine-lesioned rats: implications for Parkinson's disease. J. Neurochem. 91 2 (2004) 274-284
48. Slevin J.T., Gerhardt G.A., Smith C.D., Gash D.M., Kryscio R., and Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102 2 (2005) 216-222
49. Srivastava N., Seth K., Khanna V.K., and Agrawal A.K. Functional restoration using basic fibroblast growth factor (bFGF) infusion in Kainic acid induced cognitive dysfunction in rat: neurobehavioural and neurochemical studies. Neurochem. Res. 33 7 (2008) 1169-1177
50. Storch A., Lester H.A., Boehm B.O., and Schwarz J. Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells. J. Chem. Neuroanat. 26 2 (2003) 133-142
51. Stromberg I., Wetmore C.J., Ebendal T., Ernfors P., Persson H., and Olson L. Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosci. Res. 25 3 (1990) 405-411
52. Sugaya K. Possible use of autologous stem cell therapies for Alzheimer's disease. Curr. Alzheimer Res. 2 3 (2005) 367-376
53. Sugaya K., Alvarez A., Marutle A., Kwak Y.D., and Choumkina E. Stem cell strategies for Alzheimer's disease therapy. Panminerva Med. 48 2 (2006) 87-96
54. Sugaya K., and Brannen C.L. Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med. Hypotheses 57 6 (2001) 697-700
55. Takagi Y., Takahashi J., Saiki H., Morizane A., Hayashi T., Kishi Y., Fukuda H., Okamoto Y., Koyanagi M., Ideguchi M., Hayashi H., Imazato T., Kawasaki H., Suemori H., Omachi S., Iida H., Itoh N., Nakatsuji N., Sasai Y., and Hashimoto N. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115 1 (2005) 102-109
56. Tarasenko Y.I., Gao J., Nie L., Johnson K.M., Grady J.J., Hulsebosch C.E., McAdoo D.J., and Wu P. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J. Neurosci. Res. 85 1 (2007) 47-57
57. Temple S. Stem cell plasticity-building the brain of our dreams. Nat. Rev. Neurosci. 2 7 (2001) 513-520
58. Vorobyov V., Schibaev N., Kovalev G., and Alzheimer C. Effects of neurotransmitter agonists on electrocortical activity in the rat kainate model of temporal lobe epilepsy and the modulatory action of basic fibroblast growth factor. Brain Res. 1051 1/2 (2005) 123-136
59. Wang X., Lu Y., Zhang H., Wang K., He Q., Wang Y., Liu X., Li L., and Wang X. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int. J. Dev. Neurosci. 22 4 (2004) 175-183
60. Woodhall E., West A.K., and Chuah M.I. Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res. Mol. Brain Res. 88 1/2 (2001) 203-213
61. Wu Q.Y., Li J., Feng Z.T., and Wang T.H. Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model. Neurosci. Lett. 417 3 (2007) 281-285
62. Yuen E.C., Howe C.L., Li Y., Holtzman D.M., and Mobley W.C. Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev. 18 5 (1996) 362-368
63. Zaman V., Turner D.A., and Shetty A.K. Prolonged postlesion transplantation delay adversely influences survival of both homotopic and heterotopic fetal hippocampal cell grafts in Kainate-lesioned CA3 region of adult hippocampus. Cell Transplant. 10 1 (2001) 41-52
64. Zhang X., Jin G., Tian M., Qin J., and Huang Z. The denervated hippocampus provides proper microenvironment for the survival and differentiation of neural progenitors. Neurosci. Lett. 414 2 (2007) 115-120